Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Nunes, Edward V  [Clear All Filters]
Journal Article
A. N. C. Campbell, Miele, G. M., Nunes, E. V., McCrimmon, S., and Ghitza, U. E., Web-based, psychosocial treatment for substance use disorders in community treatment settings., Psychol Serv, vol. 9, no. 2, pp. 212-4, 2012.
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale., Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
A. N. C. Campbell, Nunes, E. V., Matthews, A. G., Stitzer, M., Miele, G. M., Polsky, D., Turrigiano, E., Walters, S., McClure, E. A., Kyle, T. L., Wahle, A., Van Veldhuisen, P., Goldman, B., Babcock, D., Stabile, P. Quinn, Winhusen, T., and Ghitza, U. E., Internet-delivered treatment for substance abuse: a multisite randomized controlled trial., Am J Psychiatry, vol. 171, no. 6, pp. 683-90, 2014.
A. N. C. Campbell, Nunes, E. V., Miele, G. M., Matthews, A., Polsky, D., Ghitza, U. E., Turrigiano, E., Bailey, G. L., VanVeldhuisen, P., Chapdelaine, R., Froias, A., Stitzer, M. L., Carroll, K. M., Winhusen, T., Clingerman, S., Perez, L., McClure, E., Goldman, B., and A Crowell, R., Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network., Contemp Clin Trials, vol. 33, no. 2, pp. 386-95, 2012.
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial., Lancet, vol. 391, no. 10118, pp. 309-318, 2018.